Back to results
US 2020/0345856 A1Published application
Conjugates of tumor necrosis factor inhibitors to functionalized polymers
AssigneeQuiaPEG Pharmaceuticals AB
InventorMarek Kwiatkowski
Life of this patent
Estimating the term…
Abstract
This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
Claims21
(canceled)
A method of preparing a compound comprising a water-soluble, non-peptidic, and non-nucleotidic polymer backbone having at least one terminus covalently bonded to a structure of formula (9):
- or a salt thereof,
- wherein:
- A is the point of covalent bonding to the terminus of the polymer backbone;
- E is O or S;
- Y represents an optionally substituted residue selected from alkyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl;
- Z1 and Z2 are independently selected from O and NH, wherein only one of Z1 and Z2 can be NH;
- L is selected from the group consisting of:
- a divalent radical of a nucleoside, alkylene, alkyleneoxyalkylene, oligomeric alkyleneoxyalkylene, and unsubstituted and substituted arylene;
- L2 is a covalent linking moiety between L on the polymer backbone and B;
- and
- B is a TNF inhibitor or a derivative thereof,
- comprising the steps of:
- (a) providing a composition comprising a compound of formula (8):
- wherein
- A is the point of covalent bonding to the terminus of the polymer backbone;
- E is O or S;
- Y represents an optionally substituted residue selected from alkyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl;
- Z1 and Z2 are independently selected from O and NH, wherein only one of Z1 and Z2 can be NH;
- L is selected from the group consisting of:
- a divalent radical of a nucleoside, an unsubstituted or substituted alkylene, alkyleneoxyalkylene, oligomeric alkyleneoxyalkylene, and an unsubstituted or substituted arylene;
- M is a protected group that when deprotected is reactive with a TNF inhibitor or a derivative thereof;
- R is a hydrophobic separation handle;
- R1 is absent or a hydrophobic separation handle;
- and
- (b) removing the hydrophobic separation handle(s);
- (c) optionally reacting the compound obtained in step (b) with an activating agent;
- and
- (d) reacting the compound obtained in step (b), or, optionally in step (c), with a TNF inhibitor or a derivative thereof.
25 more elements
Dependencies are inferred from the claim text.